Alkermes’ Richard Pops to step down after three-decade run as CEO
Source: BioPharma Dive - Latest News
One of biotech’s longest-tenured leaders, Pops steered Alkermes through several reinventions, the latest of which has made it a frontrunner in developing a new narcolepsy drug.